07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
The new Massachusetts Paid Family and Medical Leave Act (PFMLA) came into effect on October 1, 2019,...
Read More >
In a welcome development for federal government contractors, OFCCP issued its second opinion letter ...
Read More >
Washington Nationals Stay in the Fight. The Washington Nationals are heading to the World Series for...
Read More >
Channel Medsystems, Inc. v. Boston Scientific Corp., C.A. No. 2018-0673-AGB (Del. Ch. Dec. 18, 2019)...
Read More >
On June 13, 2019, the Internal Revenue Service (IRS), Department of Labor and Department of Health a...
Read More >
Soon after being elected, New Jersey’s Governor created a task force to end misclassification of in...
Read More >